Latest AI and machine learning research in lung cancer for healthcare professionals.
Identifying drug-target binding affinity (DTA) plays a critical role in early-stage drug discovery. ...
Non-small cell lung adenocarcinoma (LUAD) is a markedly heterogeneous disease, with its underlying m...
Pancreatic ductal adenocarcinoma (PDAC) is the deadliest malignant tumor, with a grim 5-year overall...
OBJECTIVE: The LungFlag risk prediction model uses individualized clinical variables to identify ind...
BACKGROUND: Endothelial cells are integral components of the tumor microenvironment and play a multi...
OBJECTIVES: The pairing of immunotherapy and radiotherapy in the treatment of locally advanced nonsm...
BACKGROUND: Lung adenocarcinoma (LUAD) is a highly aggressive tumor with one of the highest morbidit...
This review explores the applications of artificial intelligence and machine learning (AI/ML) in rad...
In the domain of histopathology analysis, existing representation learning methods for biomarkers pr...
. The primary purpose of this work is to demonstrate the feasibility of a deep convolutional neural ...
OBJECTIVES: Spingosine-1-phosphate (S1P) and ceramides are bioactive sphingolipids that influence ca...
INTRODUCTION: The current understanding of colorectal carcinogenesis is based on the adenoma-carcino...
RATIONALE AND OBJECTIVES: This study aimed to develop and validate machine learning (ML) models util...
PURPOSE: Immune checkpoint inhibitors (ICIs) have demonstrated promise in the treatment of various c...
OBJECTIVES: The lack of definitive biomarkers presents a significant challenge for chemo-immunothera...
During acquisition and reconstruction, medical images may become noisy and lose diagnostic quality. ...
BACKGROUND: Artificial intelligence (AI) models are emerging as promising tools to identify predicti...
Donor-derived cell-free DNA (dd-cfDNA) in the peripheral blood of allograft recipients has shown to...
Pancreatic ductal adenocarcinoma (PDAC) is the third leading cause of cancer-related deaths in the U...
Distinguishing between primary adenocarcinoma (AC) and squamous cell carcinoma (SCC) within non-smal...